By fitting models of cancer classification (controls, early or late cancer), we show the potential of using the level of methylated BCAT1 and/or IKZF1 DNA in blood to estimate the probability of a positive result being due to the presence of cancer (Fig 5). The gene discussed is IKZF1; the disease is cancer.